{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T19:07:26Z","timestamp":1786993646032,"version":"build-2736575974"},"reference-count":53,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2004,4,1]],"date-time":"2004-04-01T00:00:00Z","timestamp":1080777600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Leukemia Research"],"published-print":{"date-parts":[[2004,4]]},"DOI":"10.1016\/j.leukres.2003.07.005","type":"journal-article","created":{"date-parts":[[2003,10,11]],"date-time":"2003-10-11T03:27:44Z","timestamp":1065842864000},"page":"387-397","source":"Crossref","is-referenced-by-count":33,"title":["Peroxisome proliferator-activated receptor \u03b3 ligands induce growth inhibition and apoptosis of human B lymphocytic leukemia"],"prefix":"10.1016","volume":"28","author":[{"given":"Chuanbing","family":"Zang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hongyu","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maximilian G","family":"Posch","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maries","family":"Waechter","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Margit","family":"Facklam","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Martin H","family":"Fenner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Martin","family":"Ruthardt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kurt","family":"Possinger","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"H","family":"Phillip Koeffler","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elena","family":"Elstner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.leukres.2003.07.005_BIB1","first-page":"540","article-title":"New approaches to acute lymphoblastic leukemia in adults: where do we go?","volume":"27","author":"Hoelzer","year":"2000","journal-title":"Semin. Oncol."},{"key":"10.1016\/j.leukres.2003.07.005_BIB2","doi-asserted-by":"crossref","first-page":"803","DOI":"10.1016\/0092-8674(95)90193-0","article-title":"15-Deoxy-delta 12, 14-prostaglandin J2 is a ligand for the adipocyte determination factor PPAR gamma","volume":"83","author":"Forman","year":"1995","journal-title":"Cell"},{"key":"10.1016\/j.leukres.2003.07.005_BIB3","doi-asserted-by":"crossref","first-page":"813","DOI":"10.1016\/0092-8674(95)90194-9","article-title":"A prostaglandin J2 metabolite binds peroxisome proliferator-activated receptor gamma and promotes adipocyte differentiation","volume":"83","author":"Kliewer","year":"1995","journal-title":"Cell"},{"key":"10.1016\/j.leukres.2003.07.005_BIB4","doi-asserted-by":"crossref","first-page":"4189","DOI":"10.1210\/en.137.10.4189","article-title":"Thiazolidinediones produce a conformational change in peroxisomal proliferator-activated receptor-gamma: binding and activation correlate with antidiabetic actions in db\/db mice","volume":"137","author":"Berger","year":"1996","journal-title":"Endocrinology"},{"key":"10.1016\/j.leukres.2003.07.005_BIB5","doi-asserted-by":"crossref","first-page":"12953","DOI":"10.1074\/jbc.270.22.12953","article-title":"An antidiabetic thiazolidinedione is a high affinity ligand for peroxisome proliferator-activated receptor gamma (PPAR gamma)","volume":"270","author":"Lehmann","year":"1995","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.leukres.2003.07.005_BIB6","doi-asserted-by":"crossref","first-page":"798","DOI":"10.1210\/en.135.2.798","article-title":"Peroxisome proliferator-activated receptor (PPAR) gamma: adipose-predominant expression and induction early in adipocyte differentiation","volume":"135","author":"Chawla","year":"1994","journal-title":"Endocrinology"},{"key":"10.1016\/j.leukres.2003.07.005_BIB7","doi-asserted-by":"crossref","first-page":"5628","DOI":"10.1093\/nar\/22.25.5628","article-title":"Adipocyte-specific transcription factor ARF6 is a heterodimeric complex of two nuclear hormone receptors, PPAR gamma and RXR alpha","volume":"22","author":"Tontonoz","year":"1994","journal-title":"Nucleic. Acids. Res."},{"key":"10.1016\/j.leukres.2003.07.005_BIB8","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1097\/00041433-199708000-00004","article-title":"Peroxisome proliferator-activated receptor gamma and the control of adipogenesis","volume":"8","author":"Brun","year":"1997","journal-title":"Curr. Opin. Lipidol."},{"key":"10.1016\/j.leukres.2003.07.005_BIB9","doi-asserted-by":"crossref","first-page":"507","DOI":"10.2337\/diabetes.47.4.507","article-title":"PPAR-gamma: adipogenic regulator and thiazolidinedione receptor","volume":"47","author":"Spiegelman","year":"1998","journal-title":"Diabetes"},{"key":"10.1016\/j.leukres.2003.07.005_BIB10","doi-asserted-by":"crossref","first-page":"E207","DOI":"10.1152\/ajpendo.2001.281.2.E207","article-title":"TZDs inhibit vascular smooth muscle cell growth independently of the cyclin kinase inhibitors p21 and p27","volume":"281","author":"Hupfeld","year":"2001","journal-title":"Am. J. Physiol. Endocrinol. Metabol."},{"key":"10.1016\/j.leukres.2003.07.005_BIB11","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1097\/00006676-200201000-00001","article-title":"Growth inhibition and differentiation of pancreatic cancer cell lines by PPAR gamma ligand troglitazone","volume":"24","author":"Kawa","year":"2002","journal-title":"Pancreas"},{"key":"10.1016\/j.leukres.2003.07.005_BIB12","doi-asserted-by":"crossref","first-page":"294","DOI":"10.1097\/00062752-200207000-00006","article-title":"Role of peroxisome proliferator-activated receptor-gamma in hematologic malignancies","volume":"9","author":"Konopleva","year":"2002","journal-title":"Curr. Opin. Hematol."},{"key":"10.1016\/j.leukres.2003.07.005_BIB13","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1016\/S0014-5793(99)00871-6","article-title":"Activation of PPARgamma inhibits cell growth and induces apoptosis in human gastric cancer cells","volume":"455","author":"Takahashi","year":"1999","journal-title":"FEBS Lett."},{"key":"10.1016\/j.leukres.2003.07.005_BIB14","first-page":"1129","article-title":"Induction of differentiation and apoptosis by ligands of peroxisome proliferator-activated receptor gamma in non-small cell lung cancer","volume":"60","author":"Chang","year":"2000","journal-title":"Cancer Res."},{"key":"10.1016\/j.leukres.2003.07.005_BIB15","doi-asserted-by":"crossref","first-page":"400","DOI":"10.1006\/bbrc.2000.2436","article-title":"Inhibition of human lung cancer cell growth by the peroxisome proliferator-activated receptor-gamma agonists through induction of apoptosis","volume":"270","author":"Tsubouchi","year":"2000","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.leukres.2003.07.005_BIB16","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1002\/1097-4547(20000701)61:1<67::AID-JNR8>3.0.CO;2-7","article-title":"Expression of peroxisome proliferator-activated receptors (PPARS) in human astrocytic cells: PPARgamma agonists as inducers of apoptosis","volume":"61","author":"Chattopadhyay","year":"2000","journal-title":"J. Neurosci. Res."},{"key":"10.1016\/j.leukres.2003.07.005_BIB17","doi-asserted-by":"crossref","first-page":"1052","DOI":"10.1046\/j.1471-4159.2002.00899.x","article-title":"Induction of apoptosis in human and rat glioma by agonists of the nuclear receptor PPARgamma","volume":"81","author":"Zander","year":"2002","journal-title":"J. Neurochem."},{"key":"10.1016\/j.leukres.2003.07.005_BIB18","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1073\/pnas.94.1.237","article-title":"Terminal differentiation of human liposarcoma cells induced by ligands for peroxisome proliferator-activated receptor gamma and the retinoid X receptor","volume":"94","author":"Tontonoz","year":"1997","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"10.1016\/j.leukres.2003.07.005_BIB19","doi-asserted-by":"crossref","first-page":"3951","DOI":"10.1073\/pnas.96.7.3951","article-title":"Induction of solid tumor differentiation by the peroxisome proliferator- activated receptor-gamma ligand troglitazone in patients with liposarcoma","volume":"96","author":"Demetri","year":"1999","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"10.1016\/j.leukres.2003.07.005_BIB20","first-page":"3344","article-title":"Ligand for peroxisome proliferator-activated receptor gamma (troglitazone) has potent antitumor effect against human prostate cancer both in vitro and in vivo","volume":"58","author":"Kubota","year":"1998","journal-title":"Cancer Res."},{"key":"10.1016\/j.leukres.2003.07.005_BIB21","doi-asserted-by":"crossref","first-page":"10990","DOI":"10.1073\/pnas.180329197","article-title":"Effects of ligand activation of peroxisome proliferator-activated receptor gamma in human prostate cancer","volume":"97","author":"Mueller","year":"2000","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"10.1016\/j.leukres.2003.07.005_BIB22","doi-asserted-by":"crossref","first-page":"1049","DOI":"10.1016\/S0016-5085(98)70072-1","article-title":"Activation of PPARgamma leads to inhibition of anchorage-independent growth of human colorectal cancer cells","volume":"115","author":"Brockman","year":"1998","journal-title":"Gastroenterology"},{"key":"10.1016\/j.leukres.2003.07.005_BIB23","doi-asserted-by":"crossref","first-page":"1046","DOI":"10.1038\/2030","article-title":"Differentiation and reversal of malignant changes in colon cancer through PPARgamma","volume":"4","author":"Sarraf","year":"1998","journal-title":"Nat. Med."},{"key":"10.1016\/j.leukres.2003.07.005_BIB24","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1111\/j.1349-7006.1999.tb00668.x","article-title":"Peroxisome proliferator-activated receptor gamma induces growth arrest and differentiation markers of human colon cancer cells","volume":"90","author":"Kitamura","year":"1999","journal-title":"Jpn. J. Cancer Res."},{"key":"10.1016\/j.leukres.2003.07.005_BIB25","doi-asserted-by":"crossref","first-page":"1379","DOI":"10.1093\/carcin\/22.9.1379","article-title":"Activation of the PPAR pathway induces apoptosis and COX-2 inhibition in HT-29 human colon cancer cells","volume":"22","author":"Yang","year":"2001","journal-title":"Carcinogenesis"},{"key":"10.1016\/j.leukres.2003.07.005_BIB26","doi-asserted-by":"crossref","first-page":"8806","DOI":"10.1073\/pnas.95.15.8806","article-title":"Ligands for peroxisome proliferator-activated receptorgamma and retinoic acid receptor inhibit growth and induce apoptosis of human breast cancer cells in vitro and in BNX mice","volume":"95","author":"Elstner","year":"1998","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"10.1016\/j.leukres.2003.07.005_BIB27","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1016\/S0303-7207(97)04057-4","article-title":"MCF-7 and T47D human breast cancer cells contain a functional peroxisomal response","volume":"129","author":"Kilgore","year":"1997","journal-title":"Mol. Cell. Endocrinol."},{"key":"10.1016\/j.leukres.2003.07.005_BIB28","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1016\/S1097-2765(00)80047-7","article-title":"Terminal differentiation of human breast cancer through PPAR gamma","volume":"1","author":"Mueller","year":"1998","journal-title":"Mol. Cell"},{"key":"10.1016\/j.leukres.2003.07.005_BIB29","doi-asserted-by":"crossref","first-page":"1394","DOI":"10.1054\/bjoc.2000.1457","article-title":"Expression of peroxisome proliferator-activated receptor (PPAR)gamma in gastric cancer and inhibitory effects of PPARgamma agonists","volume":"83","author":"Sato","year":"2000","journal-title":"Br. J. Cancer"},{"key":"10.1016\/j.leukres.2003.07.005_BIB30","first-page":"5558","article-title":"Activation of peroxisome proliferator-activated receptor gamma by troglitazone inhibits cell growth through the increase of p27KiP1 in human pancreatic carcinoma cells","volume":"60","author":"Motomura","year":"2000","journal-title":"Cancer Res."},{"key":"10.1016\/j.leukres.2003.07.005_BIB31","first-page":"1157","article-title":"PPARgamma ligand (thiazolidinedione) induces growth arrest and differentiation markers of human pancreatic cancer cells","volume":"17","author":"Elnemr","year":"2000","journal-title":"Int. J. Oncol."},{"key":"10.1016\/j.leukres.2003.07.005_BIB32","first-page":"1027","article-title":"Growth inhibition of myeloid leukemia cells by troglitazone, a ligand for peroxisome proliferator activated receptor gamma, and retinoids","volume":"15","author":"Asou","year":"1999","journal-title":"Int. J. Oncol."},{"key":"10.1016\/j.leukres.2003.07.005_BIB33","first-page":"207","article-title":"Leukemia cell lines: in vitro models for the study of Philadelphia chromosome-positive leukemia","volume":"23","author":"Drexler","year":"1999","journal-title":"Leuk. Res."},{"key":"10.1016\/j.leukres.2003.07.005_BIB34","doi-asserted-by":"crossref","first-page":"1601","DOI":"10.1038\/sj.leu.2401510","article-title":"False human hematopoietic cell lines: cross-contaminations and misinterpretations","volume":"13","author":"Drexler","year":"1999","journal-title":"Leukemia"},{"key":"10.1016\/j.leukres.2003.07.005_BIB35","unstructured":"PE Biosystems. Rlative quantitation of gene expression. ABI Prism 7700 Sequence Detection System. 1997."},{"key":"10.1016\/j.leukres.2003.07.005_BIB36","doi-asserted-by":"crossref","first-page":"5055","DOI":"10.1021\/jm980414r","article-title":"N-(2-benzoylphenyl)-l-tyrosine PPARgamma agonists. 3. Structure\u2013activity relationship and optimization of the N-aryl substituent","volume":"41","author":"Cobb","year":"1998","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.leukres.2003.07.005_BIB37","doi-asserted-by":"crossref","first-page":"916","DOI":"10.1006\/bbrc.2001.5491","article-title":"Troglitazone inhibits growth of MCF-7 breast carcinoma cells by targeting G1 cell cycle regulators","volume":"286","author":"Yin","year":"2001","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.leukres.2003.07.005_BIB38","doi-asserted-by":"crossref","first-page":"601","DOI":"10.1146\/annurev.physiol.60.1.601","article-title":"Cell cycle regulation and apoptosis","volume":"60","author":"King","year":"1998","journal-title":"Ann. Rev. Physiol."},{"key":"10.1016\/j.leukres.2003.07.005_BIB39","doi-asserted-by":"crossref","first-page":"17042","DOI":"10.1074\/jbc.274.24.17042","article-title":"Endothelial cell apoptosis induced by the peroxisome proliferator-activated receptor (PPAR) ligand 15-deoxy-Delta12, 14-prostaglandin J2","volume":"274","author":"Bishop-Bailey","year":"1999","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.leukres.2003.07.005_BIB40","doi-asserted-by":"crossref","first-page":"764","DOI":"10.1016\/S0960-9822(01)00225-1","article-title":"Tumor suppressor and anti-inflammatory actions of PPARgamma agonists are mediated via upregulation of PTEN","volume":"11","author":"Patel","year":"2001","journal-title":"Curr. Biol."},{"key":"10.1016\/j.leukres.2003.07.005_BIB41","first-page":"568a","article-title":"Targeted induction of apoptosis in leukemias by PPARg ligation","volume":"98","author":"Tsao","year":"2002","journal-title":"Blood"},{"key":"10.1016\/j.leukres.2003.07.005_BIB42","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1038\/83336","article-title":"PPAR-gamma dependent and independent effects on macrophage-gene expression in lipid metabolism and inflammation","volume":"7","author":"Chawla","year":"2001","journal-title":"Nat. Med."},{"key":"10.1016\/j.leukres.2003.07.005_BIB43","first-page":"6213","article-title":"Anticancer effects of thiazolidinediones are independent of peroxisome proliferator-activated receptor gamma and mediated by inhibition of translation initiation","volume":"61","author":"Palakurthi","year":"2001","journal-title":"Cancer Res."},{"key":"10.1016\/j.leukres.2003.07.005_BIB44","doi-asserted-by":"crossref","first-page":"1905","DOI":"10.1093\/carcin\/20.10.1905","article-title":"Influence of J series prostaglandins on apoptosis and tumorigenesis of breast cancer cells","volume":"20","author":"Clay","year":"1999","journal-title":"Carcinogenesis"},{"key":"10.1016\/j.leukres.2003.07.005_BIB45","doi-asserted-by":"crossref","first-page":"1640","DOI":"10.1054\/bjoc.2001.1821","article-title":"Peroxisome proliferator-activated receptor gamma ligand-induced growth inhibition of human hepatocellular carcinoma","volume":"84","author":"Rumi","year":"2001","journal-title":"Br. J. Cancer"},{"key":"10.1016\/j.leukres.2003.07.005_BIB46","doi-asserted-by":"crossref","first-page":"833","DOI":"10.1006\/bbrc.1999.1049","article-title":"Troglitazone suppresses cell growth of myeloid leukemia cell lines by induction of p21WAF1\/CIP1 cyclin-dependent kinase inhibitor","volume":"261","author":"Sugimura","year":"1999","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.leukres.2003.07.005_BIB47","doi-asserted-by":"crossref","first-page":"22435","DOI":"10.1074\/jbc.M910452199","article-title":"Peroxisome proliferator-activated receptor gamma ligands inhibit retinoblastoma phosphorylation and G1\u2192S transition in vascular smooth muscle cells","volume":"275","author":"Wakino","year":"2000","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.leukres.2003.07.005_BIB48","unstructured":"Wolowiec D, Ciszak L, Kosmaczewska A, Bocko D, Teodorowska R, Frydecka I, et al. Cell cycle regulatory proteins and apoptosis in B-cell chronic lymphocytic leukemia. Haematologica 2001;86(12)1296\u20131304."},{"key":"10.1016\/j.leukres.2003.07.005_BIB49","doi-asserted-by":"crossref","unstructured":"Decker T, Schneller F, Hipp S, Miething C, Jahn T, Duyster J. et al. Cell cycle progression of chronic lymphocytic leukemia cells is controlled by cyclin D2, cyclin D3, cyclin-dependent kinase (cdk) 4 and the cdk inhibitor p27, Leukemia 2002;16(3):327\u201334.","DOI":"10.1038\/sj.leu.2402389"},{"key":"10.1016\/j.leukres.2003.07.005_BIB50","doi-asserted-by":"crossref","unstructured":"Laurora S, Pizzimenti S, Briatore F, Fraioli A, Maggio M, Reffo P, et al. Peroxisome proliferator-activated receptor ligands affect growth-related gene expression in human leukemic cells, J. Pharmacol. Exp. Ther. 2003;305(3):932\u201342.","DOI":"10.1124\/jpet.103.049098"},{"key":"10.1016\/j.leukres.2003.07.005_BIB51","doi-asserted-by":"crossref","first-page":"25573","DOI":"10.1074\/jbc.273.40.25573","article-title":"Activation of proliferator-activated receptors alpha and gamma induces apoptosis of human monocyte-derived macrophages","volume":"273","author":"Chinetti","year":"1998","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.leukres.2003.07.005_BIB52","doi-asserted-by":"crossref","first-page":"571","DOI":"10.1084\/jem.192.4.571","article-title":"Two distinct pathways leading to nuclear apoptosis","volume":"192","author":"Susin","year":"2000","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.leukres.2003.07.005_BIB53","doi-asserted-by":"crossref","first-page":"999","DOI":"10.1083\/jcb.153.5.999","article-title":"Cathepsin B acts as a dominant execution protease in tumor cell apoptosis induced by tumor necrosis factor","volume":"153","author":"Foghsgaard","year":"2001","journal-title":"J. Cell Biol."}],"container-title":["Leukemia Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0145212603002960?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0145212603002960?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,2,20]],"date-time":"2019-02-20T15:21:16Z","timestamp":1550676076000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0145212603002960"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2004,4]]},"references-count":53,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2004,4]]}},"alternative-id":["S0145212603002960"],"URL":"https:\/\/doi.org\/10.1016\/j.leukres.2003.07.005","relation":{},"ISSN":["0145-2126"],"issn-type":[{"value":"0145-2126","type":"print"}],"subject":[],"published":{"date-parts":[[2004,4]]}}}